Benedikt Schrage
Overview
Explore the profile of Benedikt Schrage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dettling A, Huber K, Kristensen S, Aradi D, Schrage B, Clemmensen P
Clin Res Cardiol
. 2025 Mar;
PMID: 40035812
Coronary revascularization represents a cornerstone in the treatment of infarct-related cardiogenic shock (CS). Early and effective antithrombotic therapy is critical and has been shown to improve mortality in most patients...
2.
Stadlbauer A, Verbelen T, Binzenhofer L, Goslar T, Supady A, Spieth P, et al.
Intensive Care Med
. 2025 Feb;
PMID: 39998658
Background: High-risk acute pulmonary embolism (PE) is a life-threatening condition necessitating hemodynamic stabilization and rapid restoration of pulmonary perfusion. In this context, evidence regarding the benefit of advanced circulatory support...
3.
Sundermeyer J, Schrage B
Eur Heart J Acute Cardiovasc Care
. 2025 Feb;
PMID: 39988742
No abstract available.
4.
Kriz M, Schrage B
Dtsch Med Wochenschr
. 2025 Feb;
150(6):280-285.
PMID: 39983763
Extracorporeal cardiopulmonary resuscitation (ECPR) is an invasive medical intervention using mechanical circulatory support for treating cardiac arrest beyond the limits of conventional cardiopulmonary resuscitation (CCPR). ECPR uses veno-arterial extracorporeal membrane...
5.
Voll F, Olivecronab G, Ferenc M, Hellig F, Schlundt C, Wohrle J, et al.
Cardiovasc Interv Ther
. 2025 Feb;
40(2):296-305.
PMID: 39918675
New-generation single-layer polytetrafluorethylene (PTFE-) or polyurethane (PU-) covered stent (CS) for the treatment of coronary artery perforation (CAP) during PCI offer high procedural efficacy. To evaluate the comparative long-term safety...
6.
Cherbi M, Vandenbriele C, Schrage B, Ughetto A, Delmas C
ASAIO J
. 2025 Jan;
PMID: 39868585
No abstract available.
7.
Dettling A, Kellner C, Sundermeyer J, Beer B, Besch L, Bertoldi L, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39823252
Aims: This study aimed to investigate incidence and predictors of weaning failure and in-hospital death after successful weaning from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock (CS)....
8.
Brunner F, Becher P, Remmel M, Weimann J, Bay B, Waldeyer C, et al.
JACC Cardiovasc Interv
. 2024 Oct;
17(20):2450-2452.
PMID: 39477651
No abstract available.
9.
Sundermeyer J, Kellner C, Beer B, Dettling A, Besch L, Blankenberg S, et al.
Eur J Heart Fail
. 2024 Oct;
27(1):40-50.
PMID: 39444297
Aims: The optimal timing for implementing mechanical circulatory support (MCS) in cardiogenic shock (CS) remains indeterminate. This study aims to evaluate patient characteristics and outcome associated with the time interval...
10.
Jung C, Wernly B, Masyuk M, Kelm M, Freund A, Poss J, et al.
Eur Heart J Acute Cardiovasc Care
. 2024 Sep;
13(10):701-708.
PMID: 39268887
Aims: The optimal revascularization strategy for patients with acute myocardial infarction (AMI), cardiogenic shock (CS), and multivessel disease remains controversial. The CULPRIT-SHOCK trial compared culprit lesion-only vs. immediate multivessel percutaneous...